From the Guidelines
Pyridostigmine is primarily used to treat myasthenia gravis, with a recommended dosing of 30-600 mg daily, and may also be used in the management of immune-related adverse events, particularly those with myasthenic symptoms, as stated in the 2022 ESMO clinical practice guideline 1.
Uses of Pyridostigmine
- Treatment of myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and fatigue
- Management of immune-related adverse events, particularly those with myasthenic symptoms
- Pretreatment against nerve agent poisoning in military settings
- Off-label uses for treating postural orthostatic tachycardia syndrome (POTS) and managing some autonomic disorders
Dosage and Administration
- Typical dosing for adults with myasthenia gravis: 30-60 mg orally every 3-4 hours while awake, adjusted based on symptom control
- Dosing for immune-related adverse events: 30 mg orally up to 600 mg daily, as needed
- Intravenous application: 1 mg i.v. corresponds to 30 mg oral pyridostigmine
Side Effects and Monitoring
- Common side effects: gastrointestinal symptoms, increased salivation and sweating
- Patients should be monitored for cholinergic crisis, which can occur with overdosage and presents with severe muscle weakness, respiratory difficulties, and excessive secretions
- The medication should be taken consistently to maintain therapeutic levels and may require dose adjustments based on individual response and tolerance
Recent Guidelines and Recommendations
- The 2022 ESMO clinical practice guideline recommends pyridostigmine as a treatment option for immune-related adverse events with myasthenic symptoms 1
- The 2024 adult strabismus preferred practice pattern recommends pyridostigmine as the first line of treatment for myasthenia gravis, but notes that about half of patients with strabismus-associated myasthenia show minimal response 1
From the FDA Drug Label
Pyridostigmine bromide is useful in the treatment of myasthenia gravis. The main use of pyridostigmine is in the treatment of myasthenia gravis 2.
- Key uses: treatment of myasthenia gravis It works by inhibiting the destruction of acetylcholine by cholinesterase, permitting freer transmission of nerve impulses across the neuromuscular junction 2.
From the Research
Pyridostigmine Uses
- Pyridostigmine is used in the symptomatic treatment of myasthenia gravis (MG) 3, 4, 5, 6, 7
- It is an anticholinesterase agent that has been used for over 50 years to treat MG 6
- Pyridostigmine is suitable as a long-term treatment in patients with generalized non-progressive milder disease, and as an adjunctive therapy in patients with severe disease who are also receiving immunotherapy 6
Efficacy and Side Effects
- Patients reported a median effectiveness of 60 and net benefit of 65 when using pyridostigmine 3
- Common side effects of pyridostigmine include flatulence, urinary urgency, muscle cramps, blurred vision, and hyperhidrosis 3
- Diarrhea, abdominal cramps, and muscle twitching are also reported as reasons to discontinue pyridostigmine 3
Administration and Dosage
- The sustained-release dosage form of pyridostigmine (SR-Pyr) can reduce the number of daily doses and improve the total quantified myasthenia gravis (QMG) score 5
- Continuing pyridostigmine till the day of surgery or omitting it on the night before surgery can provide variable results with regards to the effect of vecuronium 4
Historical Aspects
- Pyridostigmine bromide was unsuccessful in its "pioneering trials" to treat a series of MG patients, but it has become an indispensable anticholinesterase agent used worldwide to treat patients with MG 7